Gentex (NASDAQ:GNTX) Director Brian Walker Sells 5,939 Shares

Gentex Corporation (NASDAQ:GNTX) Director Brian Walker sold 5,939 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $22.98, for a total value of $136,478.22. Following the transaction, the director owned 24,205 shares of the company’s stock, valued at $556,230.90. This represents a 19.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Gentex Stock Performance

NASDAQ GNTX opened at $22.87 on Friday. The company has a market capitalization of $4.87 billion, a P/E ratio of 12.85 and a beta of 0.78. Gentex Corporation has a one year low of $20.48 and a one year high of $29.38. The stock has a 50 day moving average price of $22.19 and a 200-day moving average price of $23.08.

Gentex (NASDAQ:GNTX) last posted its earnings results on Friday, April 24th. The auto parts company reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.04. Gentex had a return on equity of 16.27% and a net margin of 14.75%.The firm had revenue of $675.44 million during the quarter, compared to the consensus estimate of $649.42 million. During the same period in the prior year, the company earned $0.42 EPS. The company’s quarterly revenue was up 17.1% compared to the same quarter last year. As a group, equities analysts predict that Gentex Corporation will post 1.92 EPS for the current fiscal year.

Gentex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Wednesday, April 8th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.1%. The ex-dividend date was Wednesday, April 8th. Gentex’s dividend payout ratio is presently 26.97%.

Key Headlines Impacting Gentex

Here are the key news stories impacting Gentex this week:

• Positive Sentiment: JPMorgan raised its price target on Gentex to $28 from $27, suggesting improved valuation expectations despite maintaining a neutral rating.
• Positive Sentiment: Zacks Research increased FY2026 EPS estimates to $1.91 from $1.89 and raised Q2 2027 and Q3 2027 earnings forecasts, signaling expectations for steady medium-term earnings growth.
• Neutral Sentiment: Gentex director Joseph B. Anderson, Jr. sold 5,939 shares at $22.98, a modest insider transaction that may add some investor caution but does not by itself indicate a major fundamental change.
• Neutral Sentiment: Analysts also nudged FY2027 EPS estimates lower to $2.13 from $2.17 and trimmed Q4 2027 and Q1 2027 forecasts, showing some near-term caution around longer-dated earnings.
• Negative Sentiment: Zacks Research lowered Q4 2026 EPS to $0.47 from $0.48 and cut Q1 2027 EPS to $0.51 from $0.54, which could slightly pressure sentiment around the next few quarters.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Weiss Ratings restated a “hold (c)” rating on shares of Gentex in a report on Thursday, January 22nd. Wall Street Zen upgraded Gentex from a “hold” rating to a “buy” rating in a report on Sunday, March 8th. Robert W. Baird increased their price target on Gentex from $25.00 to $26.00 and gave the company a “neutral” rating in a report on Monday, April 27th. UBS Group set a $26.00 price target on Gentex in a report on Sunday, April 26th. Finally, JPMorgan Chase & Co. increased their price target on Gentex from $27.00 to $28.00 and gave the company a “neutral” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $26.83.

Institutional Trading of Gentex

Several institutional investors and hedge funds have recently made changes to their positions in the business. Lazard Asset Management LLC lifted its position in shares of Gentex by 36.6% during the first quarter. Lazard Asset Management LLC now owns 230,388 shares of the auto parts company’s stock worth $5,034,000 after purchasing an additional 61,749 shares during the last quarter. Rice Hall James & Associates LLC raised its holdings in shares of Gentex by 4.5% in the first quarter. Rice Hall James & Associates LLC now owns 413,819 shares of the auto parts company’s stock valued at $9,042,000 after acquiring an additional 17,870 shares in the last quarter. Waverly Advisors LLC raised its holdings in shares of Gentex by 5.4% in the first quarter. Waverly Advisors LLC now owns 12,674 shares of the auto parts company’s stock valued at $277,000 after acquiring an additional 653 shares in the last quarter. Entropy Technologies LP raised its holdings in shares of Gentex by 248.6% in the first quarter. Entropy Technologies LP now owns 87,044 shares of the auto parts company’s stock valued at $1,902,000 after acquiring an additional 62,076 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Gentex by 21.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,995,044 shares of the auto parts company’s stock valued at $65,442,000 after acquiring an additional 534,905 shares in the last quarter. 86.76% of the stock is currently owned by institutional investors.

Gentex Company Profile

Gentex Corporation (NASDAQ: GNTX) is a global technology company specializing in the design and manufacture of automotive and aerospace products. The company’s primary business centers on automatic-dimming rearview mirrors, advanced driver-assistance systems (ADAS), and camera-based driver monitoring technologies. In the automotive sector, Gentex supplies exterior and interior mirrors with integrated electronics, connectivity features, and safety capabilities to many of the world’s leading original equipment manufacturers (OEMs).